Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.29p
   
  • Change Today:
      0.29p
  • 52 Week High: 9.80
  • 52 Week Low: 4.88
  • Currency: UK Pounds
  • Shares Issued: 201.37m
  • Volume: 532,220
  • Market Cap: £14.68m
  • RiskGrade: 510

Deal with Barclays    Trade now with Barclays Stockbrokers

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions) £ (Millions)
30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Continuing Operations        
Revenue 0.15 n/a n/a n/a
         
EBITDA (3.63) (2.93) (3.08) (2.84)
Depreciation & Amortisation (0.06) (0.06) 0.11 0.08
         
Operating Profit/(Loss) (3.70) (2.99) (2.97) (2.76)
Interest Payable n/a n/a n/a n/a
Interest Receivable/Investment Income 0.04 0.07 0.13 0.29
         
Group Profit after Interest (3.66) (2.92) (2.84) (2.47)
Share of Assoc Cos/JV Profits n/a n/a n/a n/a
         
Profit Before Tax (3.66) (2.92) (2.84) (2.47)
Tax 0.43 0.37 0.35 0.32
         
Profit After Tax (3.23) (2.55) (2.49) (2.15)
         
Discontinued Operations        
Profit After Tax n/a n/a n/a n/a
         
PROFIT FOR PERIOD (3.23) (2.55) (2.49) (2.15)
         
Attributable to:        
Equity Holders of Parent Company (3.23) (2.55) (2.49) (2.15)
Minority Interests n/a n/a n/a n/a
         
Equity Dividends cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(3.23) c(2.55) c(2.49) c(2.15)


Per Share Record - Normalised 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Continuing EPS        
Earnings per Share - Basic (5.37p) (4.27p) (10.64p) (9.92p)
Earnings per Share - Diluted (5.37p) (4.27p) (10.64p) (9.92p)
Earnings per Share - Adjusted (10.59p) (4.25p) (10.58p) (9.86p)
Continuing and Discontinued EPS        
Earnings per Share - Basic (5.37p) (4.27p) (10.64p) (9.92p)
Earnings per Share - Diluted (5.37p) (4.27p) (10.64p) (9.92p)
Earnings per Share - Adjusted (10.59p) (4.25p) (10.58p) (9.86p)
         
Dividend per Share n/a n/a n/a n/a


Key Financals 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
Shares in Issue (millions)        
Shares in Issue - Year End 69.56 59.75 59.75 21.69
Weighted Average 60.20 59.75 23.43 21.69
Diluted 60.20 59.75 23.43 21.69
         
Performance Ratios        
Continuing Operations        
Operating Margin (2,386.45%) n/a n/a n/a
Return on Capital Employed n/a n/a n/a n/a
Continuing Operations & Discontinued Operations        
Return on Equity (64.70%) (45.83%) (31.18%) (51.40%)
         
Financial Status        
Continuing Operations        
Interest Cover - Continuing n/a n/a (2,841.00) (2,466.00)
Revenue per Share 0.26p n/a n/a n/a
Pre-Tax Profit Per Share - Continuing (6.09p) (4.88p) (12.13p) (11.37p)
         
Market Data        
Continuing Operations        
Earnings Per Share Growth - Basic n/a n/a n/a n/a
Earnings Per Share Growth - Diluted n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a
Continuing Operations & Discontinued Operations        
Earnings per Share - Company Adjusted n/a n/a n/a n/a
Earnings per Share - Diluted n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a
         
Market Capitalisation £ (Millions) 16.94 13.96 12.03 9.49
Dividend per Share n/a n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page